Riluzole inhibited the expression of β-catenin, Wnt3a, Wnt5a, WSP, TCF and LEF in both MIA PaCa-2 and AsPC-1 pancreatic cancer cells (Fig. 3A–F and I–N). Here, WNT5A is linked to pancreatic neoplasm.